Veracyte (VCYT) FCF Margin (2012 - 2026)

Veracyte has disclosed FCF Margin across 15 years of filings, most recently posting 23.19% for Q1 2026.

• FCF Margin for Q1 2026 came in at 23.19%, up 2010.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 30.03% (up 1101.0% YoY), and the FY2025 annual result was 25.91%, up 933.0% from the prior year.
• FCF Margin came in at 23.19% for Q1 2026 at Veracyte, down from 36.34% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 36.34% in Q4 2025 to a low of 16.71% in Q1 2022.
• The 5-year median for FCF Margin is 15.09% (2023), against an average of 12.82%.
• Across the five-year window, FCF Margin surged 9706 bps in 2022 and plunged 646 bps in 2024, its largest moves.
• Veracyte's FCF Margin stood at 9.8% in 2022, then slumped by 38 bps to 6.13% in 2023, then jumped by 320 bps to 25.7% in 2024, then surged by 41 bps to 36.34% in 2025, then sank by 36 bps to 23.19% in 2026.
• The last three FCF Margin figures came in at 23.19% (Q1 2026), 36.34% (Q4 2025), and 33.69% (Q3 2025), per Business Quant data.